Progenics Pharmaceuticals - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsProgenics Pharmaceuticals

Progenics Pharmaceuticals(PGNX)

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Azedra	Iobenguane i	2018-07-30		—

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Iobenguane i 131

,

left ventricular dysfunction

,

ventricular dysfunction

,

Lutetium dotatate lu-177

,

prostatic neoplasms

,

,

breast neoplasms

,

,

,

small cell lung carcinoma

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

,

,

neuroendocrine tumors

,

pancreatic neoplasms

,

stomach neoplasms

,

intestinal neoplasms

Aglatimagene besadenovec

,

triple negative breast neoplasms

,

pharmacokinetics

,

healthy volunteers/patients

,

pharmacological phenomena

,

,

breast neoplasms

,

,

neoplasm metastasis

,

,

ovarian neoplasms

,

non-small-cell lung carcinoma

,

pancreatic neoplasms

,

colorectal neoplasms

,

,

uterine cervical neoplasms

,

endometrial neoplasms

,

stomach neoplasms

,

urinary bladder neoplasms

,

small cell lung carcinoma

,

biliary tract neoplasms

,

,

,

hereditary breast and ovarian cancer syndrome

,

,

head and neck neoplasms

,

dna repair-deficiency disorders

,

,

ovarian epithelial carcinoma

,

,

hypersensitivity

,

,

prostatic neoplasms

,

castration-resistant prostatic neoplasms

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

,

disease susceptibility

,

hepatocellular carcinoma

,

liver neoplasms

Iobenguane i-131

,

neuroendocrine tumors

,

,

,

myeloid leukemia acute

,

myeloid leukemia

,

deficiency diseases

,

paraproteinemias

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

breast neoplasms

,

immune system diseases

,

hematologic neoplasms

,

type 2 diabetes mellitus

,

,

metabolic diseases

,

,

,

immunoglobulin g4-related disease

,

,

falciparum malaria

,

,

,

,

,

polycystic kidney diseases

,

autosomal dominant polycystic kidney

,

,

renal insufficiency

,

hematologic diseases

,

blood protein disorders

,

neoplasms by histologic type

,

prostatic neoplasms

,

circulating neoplastic cells

,

heart transplantation

,

non-small-cell lung carcinoma

,

,

,

nasopharyngeal carcinoma

,

nasopharyngeal neoplasms

,

esophageal neoplasms

,

,

neoplasm metastasis

,

,

aplastic anemia

,

multiple myeloma

,

plasma cell neoplasms

,

hypercholesterolemia

,

hyperlipoproteinemia type ii

,

meningococcal infections

,

hemolytic anemia autoimmune

,

,

meningococcal meningitis

,

stomach neoplasms

,

,

kidney diseases

,

gaucher disease

,

smoldering multiple myeloma

,

,

chronic renal insufficiency

,

hyperphosphatemia

,

multiple sclerosis

,

,

homozygous familial hypercholesterolemia

,

,

,

healthy volunteers/patients

,

,

glycogen storage disease type ii

,

glycogen storage disease

,

atopic dermatitis

,

,

,

,

diabetes mellitus

,

,

glycogen storage disease type iii

,

non-hodgkin lymphoma

,

,

postmenopausal osteoporosis

,

lymphoproliferative disorders

Piflufolastat f-18

prostatic neoplasms

,

Piflufolastat f18

prostatic neoplasms

,

,

,

penile induration

,

retinal vein occlusion

,

,

macular degeneration

,

,

,

epiretinal membrane

,

,

muscle spasticity

,

,

penile induration

,

,

retinal vein occlusion

,

,

muscle spasticity

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use